AI-Native Billing Startups Burned Hundreds of Millions: What Now?

Your prospect just heard a pitch from a startup with hundreds of millions in funding and a promise of zero humans. Should a medical billing AI pitch like that keep you up at night? In this final part of our series on competing with AI-native companies, we look at two heavily funded examples, one in revenue cycle management and one in claims administration. We challenge the hype, question the funding logic, and reveal what these companies' own pivots say about the model. What You'll Learn: Why did well-funded teams with elite investors struggle to make AI-native billing work? What does a "hybrid" model really mean when you look closely? Why does venture funding push startups toward the riskiest approach? How can a smaller company win deals against a competitor that can buy business? The takeaway: you don't need to fear medical billing AI startups, because a modular, iterative technology strategy built on strong operations is the stronger long-term play.